Rheumatology Unit, AOU Meyer, IRCCS, Florence, Italy;Giulia Inguscio, MD, is a pediatric resident at Meyer Children's Hospital IRCCS, Florence. She graduated cum laude from Vita-Salute San Raffaele University, Milan, and holds a Level II Master's in Pediatric Dermatology from the University of Florence. In 2026, she completed a clinical and research observership in pediatric rheumatology at Alder Hey Children's Hospital and the University of Liverpool, working on chronic non-bacterial osteomyelitis.

Department of Immunology-Rheumatology, CHU Saint-Justine, University of Montréal, Canada;Dr. Irene Bellicini is a Pediatric Immunology and Rheumatology fellow at CHU Sainte-Justine, University of Montréal, Canada. She completed her pediatric residency in Italy and has clinical and research experience in pediatric rheumatology, immunology, and Kawasaki disease, including a research collaboration with the Kawasaki Disease Research Center at Rady Children's Hospital, University of California San Diego (USA). Her current research focuses on Kawasaki disease, immune-mediated inflammatory disorders, and novel therapeutic strategies, with particular interest in vasculitis and pediatric autoimmune diseases.

Department of Pediatric Rheumatology and CEREMAIA, FHU Inflamme, ERN RITA member;Bicêtre Hospital, APHP, and University of Paris Saclay;Professor Isabelle Koné-Paut is particularly recognized for her research, publications and work in coordinating treatment protocols for Kawasaki disease. Based in France at the Kremlin-Bicêtre University Hospital, she plays a major role within the Health Network for Rare Autoimmune and Autoinflammatory Diseases (FAI2R). She co-coordinated the drafting of the National Diagnostic and Care Protocol (PNDS) for Kawasaki disease, and she also helped to inform the European recommendations (SHARE). Her research actively focuses on severe or treatment-resistant forms of the disease, in particular the evaluation of innovative therapies such as anti-IL-1 (interleukin-1) treatments to combat vasculitis. She has been elected as the first president of the EUROKIDS society.

Division of Pediatric Cardiology, CHU Sainte-Justine, University of Montréal, Canada;Nagib DAHDAH, MD, MBA, is a pediatric cardiologist and clinical researcher at the CHU Sainte-Justine, University of Montréal, Montréal, Canada. Dr. Dahdah, a renowned Kawasaki disease expert, has a track record in Kawasaki disease research for the advancement of science, patient care and advocacy for Kawasaki disease. Dr. Dahdah is the former president of the 14th International Kawasaki Disease Symposium (Montreal 2024) and concept founder of the International Kawasaki Disease Society (www.ikds.org).

Pediatric Emergency Unit, IRCCS Azienda Ospedaliero Universitaria di Bologna, Italy.;Marianna Fabi is a pediatric cardiologist at Sant’Orsola University Hospital, Bologna. She graduated in Medicine and Surgery and completed her residency in Pediatrics at the University of Bologna (Alma Mater Studiorum). Her research focuses on Kawasaki disease and MIS-C, including the inability of Asian risk scores to predict IVIG resistance and coronary lesions in an Italian cohort, gastrointestinal presentation as a possible red flag for severe disease, circulating endothelial cells as a marker of endothelial damage, and fecal calprotectin combined with initial coronary dimensions to predict persistence of coronary lesions. She also developed a scoring system to guide differential diagnosis between KD, MIS-C and adenoviral infection (DOI: 10.1007/s00431-023-05142-6) and contributes to the International Kawasaki Disease Registry.